Bcl-x(L) as prognostic marker and potential therapeutic target in cholangiocarcinoma

Intrahepatic, perihilar, and distal cholangiocarcinoma (iCCA, pCCA, dCCA) are highly malignant tumours with increasing mortality rates due to therapy resistances. Among the mechanisms mediating resistance, overexpression of anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-x(L), Mcl-1) is particularly impor...

Descripción completa

Detalles Bibliográficos
Autores: Hoffmeister-Wittmann, P. (Paula)|||/items/4868640e-3240-404c-a690-b865a92edac7, Mock, A. (Andreas)|||/items/85c787f8-0cb4-4b70-a432-40434b8454aa, Nichetti, F. (Federico)|||/items/b8f8287d-32a7-4a5c-af1b-a96218172149, Korell, F. (Felix)|||/items/494aa56c-e92d-4fd5-b34f-17d7e0d718e6, Heilig, C.E. (Christoph E.)|||/items/7fb2b58b-cfd2-4ff1-9119-8766b65b3db0, Scherr, A.L. (Anna Lena)|||/items/72c5402f-954b-4ad8-9f87-03fa16a95028, Günther, M. (Michael)|||/items/82ea36ff-0714-4cba-999d-0d1d0ec149fa, Albrecht, T. (Thomas)|||/items/0e1b20ff-d4dd-4b80-9fec-40732fca7452, Kelmendi, E. (Eblina)|||/items/c8f0d12b-9c45-494b-b375-efc77a2695b3, Xu, K. (Kaiyu)|||/items/878384e6-2c0c-4862-9519-b21774751d07, Nader, L. (Luisa)|||/items/d8272fe1-6706-492b-b30f-0ddaacfd95e9, Kessler, A. (Annika)|||/items/dfd7592b-e15e-49b4-bec1-2ca94c472d00, Schmitt, N. (Nathalie)|||/items/a0808ccb-8bbd-4001-9762-a552b03663c1, Fritzsche, S. (Sarah)|||/items/3aaef13f-d57d-4c68-8929-b19a9baad69b, Weiler, S. (Sofia)|||/items/d9599a2f-1455-421f-85de-f8e2667fad5f, Sobol, B. (Benjamin)|||/items/f2a7884f-4f92-4c53-bfdf-9c6be1bb8ba0, Stenzinger, A. (Albrecht)|||/items/178efa10-9369-4a6c-a811-57554daa9192, Boeck, S. (Stefan)|||/items/89f1aa00-85cc-4206-9086-ee8475b3ca97, Westphalen, C.B. (Christoph B.)|||/items/62d44a3e-9aeb-4546-a0d8-4131c3a2f81a, Schulze-Osthoff, K. (Klaus)|||/items/385e1ec1-1b84-46a8-96c0-daae859618e2, Trojan, J. (Jörg)|||/items/24929b81-6829-4a40-b886-bd4356930b88, Kindler, T. (Thomas)|||/items/6d729f2f-95b3-4967-8439-53b4befa1e4e, Weichert, W. (Wilko)|||/items/75f915a0-e4b1-416d-9651-9f7322f98022, Spiekermann, K. (Karsten)|||/items/65c7b784-c8c4-4c69-a3dd-52932d30f816, Bitzer, M. (Michael)|||/items/c2698812-6cbc-4e49-ab45-cc8da14d5222, Folprecht, G. (Gunnar)|||/items/f5c52e4d-c584-4e81-8cf2-d8ec7748a172, Illert, A.L. (Anna L.)|||/items/ba9bfc47-e87a-4951-8688-813c37e5cd19, Boerries, M. (Melanie)|||/items/78ba45cb-ce42-49c8-84a3-37f84c1c10f1, Klauschen, F. (Frederick)|||/items/a7e2a290-b996-418b-ac95-0f7cbca5041a, Ochsenreiter, S. (Sebastian)|||/items/cf93184b-09f3-4cf6-b933-0f20871dcedf, Siveke, J. (Jens)|||/items/987fff58-f072-4915-bc9c-d7bdae5d0445, Bauer, S. (Sebastian)|||/items/d9bc7648-9fd7-4c77-b635-058da08b4bb0, Glimm, H. (Hanno)|||/items/5a43df86-4578-4059-9fcc-1388208cb7ff, Brors, B. (Benedikt)|||/items/d48430e5-b405-4610-a860-bc87c64b80c0, Hüllein, J. (Jennifer)|||/items/ab7dbe85-570c-483c-8ebf-3eb81d56518d, Hübschmann, D. (Daniel)|||/items/d446d565-a3e5-4d8b-ba52-c00198cbc376, Uhrig, S. (Sebastian)|||/items/87cc3c0b-7a20-4624-819a-3f3c5d4e3148, Horak, P. (Peter)|||/items/5f13fb7a-375a-43db-bbea-0b14f4d8490b, Kreutzfeld, S. (Simon)|||/items/4b1e9dfb-2e76-4799-af31-05b2316f28d4, Banales, J.M. (Jesús M.)|||/items/0c1309ae-e4e4-4e85-b2f1-567a388889d5, Springfeld, C. (Christoph)|||/items/3d76f885-05c8-4cb3-9870-cbcb16f2b6fd, Jäger, D. (Dirk)|||/items/cf855890-b716-4b9f-aae0-9ba45002908b, Schirmacher, P. (Peter)|||/items/5ae47745-0b69-46b0-81a1-5928f3a830b9, Roessler, S. (Stephanie)|||/items/4816c9e1-0b0f-431c-a238-b9178d2613f4, Ormanns, S. (Steffen)|||/items/a0d53bd8-de44-4411-92cc-47e2b1df195a, Goeppert, B. (Benjamin)|||/items/1541ecf3-38ac-41eb-8b73-b29e14d38ab5, Fröhling, S. (Stefan)|||/items/2d90a3bd-1f00-4b5c-a12c-f0cb69301b54, Köhler, B.C. (Bruno C.)|||/items/4dd7f58b-2a31-42cb-b6fc-dd2ad7480203
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/65016
Acceso en línea:https://hdl.handle.net/10171/65016
Access Level:acceso abierto
Palabra clave:Apoptosis
Bcl-2
Bcl-x(L)
Chemotherapy
Cholangiocarcinoma
Mcl-1
Descripción
Sumario:Intrahepatic, perihilar, and distal cholangiocarcinoma (iCCA, pCCA, dCCA) are highly malignant tumours with increasing mortality rates due to therapy resistances. Among the mechanisms mediating resistance, overexpression of anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-x(L), Mcl-1) is particularly important. In this study, we investigated whether antiapoptotic protein patterns are prognostically relevant and potential therapeutic targets in CCA. Bcl-2 proteins were analysed in a pan-cancer cohort from the NCT/DKFZ/DKTK MASTER registry trial (n = 1140, CCA n = 72) via RNA-sequencing and transcriptome-based protein activity interference revealing high ranks of CCA for Bcl-x(L) and Mcl-1. Expression of Bcl-x(L), Mcl-1, and Bcl-2 was assessed in human CCA tissue and cell lines compared with cholangiocytes by immunohistochemistry, immunoblotting, and quantitative-RT-PCR. Immunohistochemistry confirmed the upregulation of Bcl-x(L) and Mcl-1 in iCCA tissues. Cell death of CCA cell lines upon treatemnt with specific small molecule inhibitors of Bcl-x(L) (Wehi-539), of Mcl-1 (S63845), and Bcl-2 (ABT-199), either alone, in combination with each other or together with chemotherapeutics was assessed by flow cytometry. Targeting Bcl-x(L) induced cell death and augmented the effect of chemotherapy in CCA cells. Combined inhibition of Bcl-x(L) and Mcl-1 led to a synergistic increase in cell death in CCA cell lines. Correlation between Bcl-2 protein expression and survival was analysed within three independent patient cohorts from cancer centers in Germany comprising 656 CCA cases indicating a prognostic value of Bcl-x(L) in CCA depending on the CCA subtype. Collectively, these observations identify Bcl-x(L) as a key protein in cell death resistance of CCA and may pave the way for clinical application.

Similares en LA Referencia